Semax is a neuropeptide originally developed in Russia during the 1980s to address circulatory issues such as heart attacks, strokes, and high blood pressure. While it is approved for clinical use in Russia, it has not yet received approval in other countries. But that’s the problem with much of the American healthcare system — there...Read More